ArticleLeukemia & lymphoma2024

Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Matthew M Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.